Clene Inc (CLNN)
0.3772
-0.01
(-2.18%)
USD |
NASDAQ |
May 17, 16:00
0.3772
0.00 (0.00%)
After-Hours: 20:00
Clene Debt to Equity Ratio: 6.359 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 6.359 |
December 31, 2023 | 1.991 |
September 30, 2023 | 1.226 |
June 30, 2023 | 1.20 |
March 31, 2023 | -16.21 |
December 31, 2022 | 7.930 |
September 30, 2022 | -2.199 |
Date | Value |
---|---|
June 30, 2022 | -35.99 |
March 31, 2022 | 9.602 |
December 31, 2021 | 1.515 |
September 30, 2021 | 3.372 |
June 30, 2021 | -0.5693 |
March 31, 2021 | -0.0511 |
December 31, 2020 | 5.716 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-35.99
Minimum
Jun 2022
9.602
Maximum
Mar 2022
-1.150
Average
1.370
Median
Debt to Equity Ratio Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.00 |
IGC Pharma Inc | 0.0152 |
NovaBay Pharmaceuticals Inc | 6.294 |
Protalix BioTherapeutics Inc | 0.6856 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 45.07M |
Total Liabilities (Quarterly) | 40.80M |
Shareholders Equity (Quarterly) | 4.264M |
Current Ratio | 1.226 |
Net Debt Paydown Yield | -0.53% |